Related Experiment Video
Updated: Aug 18, 2025

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.6K
Do changes in persistent organic pollutants after bariatric surgery cause endocrine disruption?
Aina Jansen1, Jan O Aaseth2, Jan L Lyche3
1Department of Surgery, Innlandet Hospital Trust, N-2819 Gjøvik, Norway.
Chemosphere
|December 5, 2022
Summary
Bariatric surgery releases persistent organic pollutants (POPs), which are strongly associated with increased adiponectin levels. This finding suggests POPs may influence metabolic functions post-surgery.
Area of Science:
- Endocrinology
- Environmental Health
- Bariatric Surgery
Background:
- Bariatric surgery induces significant weight loss, endocrine shifts, and the release of persistent organic pollutants (POPs).
- Released POPs may contribute to endocrine disruption, necessitating further investigation into their effects.
Purpose of the Study:
- To explore the associations between persistent organic pollutants (POPs) and key hormones (adiponectin, leptin, ghrelin) in individuals undergoing bariatric surgery.
- To investigate the impact of bariatric surgery on POP levels and their relationship with metabolic markers.
Main Methods:
- Analysis of adiponectin, leptin, ghrelin, and various POPs (HCB, p,p'-DDE, PCB 118, sum 6 PCB) in 63 severely obese subjects.
- Measurements were taken before and 12 months after bariatric surgery to assess changes and correlations.
Main Results:
- Significant increases in adiponectin and all measured POPs were observed post-surgery, alongside a decrease in leptin.
- A strong, highly significant association was found between adiponectin levels and all POPs.
- The increase in hexachlorobenzene (HCB) alone accounted for 38% of the variation in adiponectin.
Conclusions:
- The POP-associated increase in adiponectin may have significant clinical implications, warranting further research into its causality and mechanisms.
- The metabolic effects of POPs released during bariatric surgery require additional evaluation due to adiponectin's complex clinical roles.
Related Concept Videos
Chronic Pancreatitis I: Introduction
132
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
132
Obesity
578
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
578
Factors Affecting Drug Biotransformation: Biological
203
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
203

